Onderneming Isodiol International Inc. Canadian Securities Exchange
Aandelen
ISOL
CA46500L2003
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100,0
%
| 19 | 100,0 % | 22 | 100,0 % | +16,26% |
Verkoop per regio
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 19 | 100,0 % | 22 | 100,0 % | +16,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14-02-19 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 01-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Director/Board Member | - | 21-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 98 334 359 | 98 334 359 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,18 mld. | |
+3,98% | 3,16 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |